PRESS RELEASE published on 03/19/2025 at 15:27, 1 year 4 months ago Inside Information / Other news releases Valerio Therapeutics announces new board members and their positions in other companies as of March 19, 2025 Board Members Positions Valerio Therapeutics Other Companies March 19 2025
BRIEF published on 03/19/2025 at 12:35, 1 year 4 months ago Valerio Therapeutics Board Meeting Decisions Director Changes Shareholder Meeting Share Split Board Resolutions Article Amendments
BRIEF published on 03/19/2025 at 12:35, 1 year 4 months ago Décisions du conseil d'administration de Valerio Therapeutics Assemblée Des Actionnaires Fractionnement Des Actions Changements De Directeur Résolutions Du Conseil D'administration Modifications D'articles
PRESS RELEASE published on 03/19/2025 at 12:30, 1 year 4 months ago Informations privilégiées / Autres communiqués Rapport du conseil d'administration de VALERIO THERAPEUTICS pour l'AG mixte des actionnaires du 9 avril 2025 concernant révocations, cooptations, division du nominal des actions et modifications statutaires Cooptation Revocation Valerio Therapeutics AG Mixte Division Du Nominal
PRESS RELEASE published on 03/19/2025 at 12:30, 1 year 4 months ago Inside Information / Other news releases Valerio Therapeutics Board of Directors convenes a General Meeting with resolutions on director dismissals, co-optation, share division, bylaws amendment, and formalities powers Board Of Directors General Meeting Resolutions Valerio Therapeutics Share Division
BRIEF published on 02/04/2025 at 10:40, 1 year 6 months ago Valerio Therapeutics opts for strategic refocusing Clinical Trials Oncology Financial Strategy Medical Innovation Valerio Therapeutics
BRIEF published on 02/04/2025 at 10:40, 1 year 6 months ago Valerio Therapeutics opte pour un recentrage stratégique Innovation Médicale Stratégie Financière Essais Cliniques Oncologie Valerio Therapeutics
PRESS RELEASE published on 02/04/2025 at 10:35, 1 year 6 months ago Inside Information / Other news releases Valerio Therapeutics refocuses strategy, discontinuing clinical trials for financial reasons. Focus on early-stage drug development Clinical Trials Financial Challenges Valerio Therapeutics Strategy Refocus Early-stage Development
PRESS RELEASE published on 02/04/2025 at 10:35, 1 year 6 months ago Informations privilégiées / Autres communiqués Valerio Therapeutics annonce un recentrage stratégique pour se concentrer sur le développement de médicaments early-stage et assurer une croissance durable. La société cherche un accord de financement à long terme Développement Financement Restructuration Médicaments Valerio Therapeutics
BRIEF published on 10/01/2024 at 00:56, 1 year 10 months ago Valerio Therapeutics Reports First Half 2024 Financial Results Financial Results R&D Clinical Trial Valerio Therapeutics Single Domain Antibodies
Published on 08/15/2026 at 00:50, 14 hours 52 minutes ago Revive Therapeutics Reports Grant of Options
Published on 08/15/2026 at 00:15, 15 hours 27 minutes ago Full Circle Lithium Announces Closing of Private Placement
Published on 08/14/2026 at 23:45, 15 hours 57 minutes ago AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 08/14/2026 at 23:25, 16 hours 17 minutes ago NuRAN Wireless Closes $7.6 Million Financing
Published on 08/14/2026 at 23:00, 16 hours 42 minutes ago Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call
Published on 08/15/2026 at 15:05, 37 minutes ago Brook Gaming Officially Launches Sniper 2 Flagship Keyboard and Mouse Converter for Cross-Platform Console Gaming
Published on 08/15/2026 at 08:05, 7 hours 37 minutes ago SKYWORTH Solar to Launch SolaMate Balcony Solar System on Joybuy Germany on August 15
Published on 08/14/2026 at 18:15, 21 hours 27 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/13/2026 at 18:00, 1 day 21 hours ago Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 3 days 21 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 3 days 22 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 4 days 21 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 4 days 21 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
